Norma Ann Provencio
CIK 1343811 · last filed 2025-11-18
Norma Ann Provencio is a corporate insider who has filed 102 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for BZH, was dated Nov 18, 2025. Across all open-market trades the lifetime net is +$236.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.17M
2
102
$236.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BZH | Director | 115,988 | $27.37 | $3.17M | $158.4K | 17 | 2025-11-18 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Director | 2,500 | — | — | $77.6K | 39 | 2010-09-30 |
Recent Filings
102 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-18 | BZH | Grant (A) | +7,199 | $0 | EDGAR |
| 2025-02-10 | BZH | Buy (P) | +5,000 | $109.7K | EDGAR |
| 2024-11-19 | BZH | Grant (A) | +5,051 | $0 | EDGAR |
| 2023-11-21 | BZH | Grant (A) | +6,024 | $0 | EDGAR |
| 2022-11-16 | BZH | Grant (A) | +14,181 | $0 | EDGAR |
| 2021-11-16 | BZH | Grant (A) | +7,679 | $0 | EDGAR |
| 2020-11-18 | BZH | Grant (A) | +9,177 | $0 | EDGAR |
| 2019-11-19 | BZH | Grant (A) | +8,002 | $0 | EDGAR |
| 2018-11-19 | BZH | Grant (A) | +10,183 | $0 | EDGAR |
| 2017-11-17 | BZH | Grant (A) | +4,887 | $0 | EDGAR |